CBD improves neuropsychiatric symptoms in tuberous sclerosis complex: EpiCom trial insights
The EpiCom trial highlights CBD neuropsychiatric symptoms tuberous sclerosis benefits beyond seizure control. This study provides evidence that CBD may improve behavioral and cognitive symptoms in TSC patients. These findings suggest new therapeutic…
Real-world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2-q13.1 duplication and deletion syndromes: A multicenter study.
This multicenter retrospective study evaluated the effectiveness and safety of highly purified cannabidiol epilepsy treatment in 22 patients with 15q11.2-q13.1 duplication and deletion syndromes. Results showed significant seizure reductions and improved…
CurePSP Leads Bipartisan Briefing to Boost PSP, CBD, and MSA Research
Rare neurodegenerative diseases research is critical for conditions like PSP, CBD, and MSA, which currently lack effective treatments. CurePSP convened a bipartisan congressional briefing to increase awareness and funding. This advocacy aims to…